Herbert Irving Comprehensive Cancer Center

Herbert Irving Comprehensive Cancer Center (HICCC) is a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, founded in 1911 at Columbia University Medical Center and part of the New York–Presbyterian Hospital Complex. The HICCC has more than 250 faculty members, 12 core facilities, and eight research programs within three divisions.

There are eight research programs at HICCC divided into three divisions. The basic science division includes programs in cancer regulatory networks and cancer genetics and epigenetics. Programs in the disease-specific division focus on breast cancer, hematological cancer, prostate cancer, and neuro-oncology. The population science division includes cancer epidemiology and prevention, control, and disparities.

The center is currently receiving over $33 million in funding from the NIH.

Patients are treated at NewYork-Presbyterian Hospital. HICCC physicians treat more than 3,500 patients annually. There are over 200 clinical trials available to patients.

HICCC first opened in 1911 as the Institute for Cancer Research and received its NCI designation in 1972, being promoted to comprehensive status in 1979. HICCC is currently led by Stephen G. Emerson and Gary Schwartz.

...
Wikipedia